ProShare Advisors
UTMD icon

ProShare Advisors’s Utah Medical Products UTMD Stock Holding History

ProShare Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-123,764
Closed -$11.6M – 1681
2020
Q1 		$11.6M Buy
123,764
+5,243
+4% +$487K 0.08% 189
2019
Q4 		$12.8M Buy
118,521
+4,152
+4% +$421K 0.06% 311
2019
Q3 		$11M Buy
+114,369
New +$10.6M 0.06% 302

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

ProShare Advisors's UTMD Position: Q2 2020 in Review

ProShare Advisors sold out of Utah Medical Products (UTMD) in Q2 2020, closing a stake of 123,764 shares — an estimated $11.6M sold.

ProShare Advisors first reported a position in UTMD in Q3 2019 and held it in 3 quarters. The position peaked at $12.8M in Q4 2019. 93 funds tracked by Wall St. Rank hold UTMD as of Q2 2020.

  • ProShare Advisors reported no remaining Utah Medical Products position as of Q2 2020 after selling out during the quarter.
  • ProShare Advisors sold 123,764 Utah Medical Products shares in Q2 2020, an estimated $11.6M.
  • ProShare Advisors first reported a position in Utah Medical Products in Q3 2019 and held it in 3 quarters.
  • ProShare Advisors's Utah Medical Products position peaked at $12.8M in Q4 2019.
  • 93 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2020.

Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.